This blog highlights the key advantages and drawbacks of hybridoma development and phage display for a monoclonal antibody production in order to help you determine the best method for your needs.

Enzolytics, Inc. has announced a coherent protocol that it is executing to meet the Company's objective of producing monoclonal antibodies for veterinary application utilizing Hybridoma and Phage ...